Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2005
05/05/2005US20050095605 Photoactive planktonic protein with improved optical characteristic for use as reporter molecule in imaging systems
05/05/2005US20050095604 Novel modulators of amyloid-beta production and uses thereof
05/05/2005US20050095594 Nucleic acid sequences of hyperplasies and tumors of the thyroid
05/05/2005US20050095593 T cell regulatory genes associated with immune disease
05/05/2005US20050095590 Brain expressed cap-2 gene and protein associated with bipolar disorder
05/05/2005US20050095589 Amino acid sequences of human secreted peptides and proteins that are related to the epidermal growth factor protein subfamily, as well as allelic variants and other mammalian orthologs thereof; for use in human therapeutics and diagnostics
05/05/2005US20050095587 Molecules for disease detection and treatment
05/05/2005US20050095586 Expression vector comprising nucleotide sequences coding homeobox proteins for use in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy
05/05/2005US20050095584 Method for determining early HCV seroconversion
05/05/2005US20050095581 Viral polypeptide for use as tool in generating immunoreactive particle for diagnosis, prevention and treatment of viral infection
05/05/2005US20050095270 Introducing large volumes of therapeutics without hearing loss via round window membrane, semicircular canals, cochleostomy and/or stapes footplate
05/05/2005US20050095258 Vaccine inhibiting gonadotropin releasing hormone activity in cattle and protecting against bovine herpes virus type 1; polynucleotides, vectors, transformed cells
05/05/2005US20050095257 Cancer and viral infections vaccines; increased immunogenicity
05/05/2005US20050095256 Nucleotide sequence encoding merozoite surface protein-1 of plasmodium strain with reduced adenine and thymine; vectors, organisms, host cells
05/05/2005US20050095255 For primates; p42 nucleic acid encoding a p42 polypeptide from the C-terminal processing fragment of Plasmodium falciparum major merozoite surface protein gp195 which hybridizes under high stringency conditions
05/05/2005US20050095254 DNA immunization against Chlamydia infection
05/05/2005US20050095253 inducing cancer immune response
05/05/2005US20050095252 Promoter for high-throughput screening for inhibitors against Mycobacteria under low carbon conditions
05/05/2005US20050095249 Protein markers for lung cancer and use thereof
05/05/2005US20050095247 Diagnosis and treatment of infectious diseases through indel-differentiated proteins
05/05/2005US20050095241 Estrogen receptor modulators and uses thereof
05/05/2005US20050095240 NaCT as a target for lifespan expansion and weight reduction
05/05/2005US20050095237 Antibodies that kill P2Y10-expressing cells linked to diseases such as inflammatory disorders, autoimmune diseases, allergic reaction, organ and tissue rejection, and mast cell diseases; immunotherapy; use of vaccines; diagnosis
05/05/2005US20050095236 Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
05/05/2005US20050095227 Treating heart failure
05/05/2005US20050095224 Compositions and method for treating hepatitis virus infection
05/05/2005US20050095201 Protein or peptide containing asparagyl-4-aminobutane and/or glutamyl-4-aminobutane residues; diagnostic magnetic resonance imaging
05/05/2005US20050095198 Annexin derivatives with endogenous chelation sites
05/05/2005CA2446460A1 Identification of a novel bovine immunodeficiency-like virus tat protein with enhanced transactivation activity
05/04/2005EP1528104A1 MEG1 endosperm-specific promoters and genes
05/04/2005EP1528103A1 'Osteoclast-inhibitory factor' (OCIF) derived proteins and methods for producing the proteins
05/04/2005EP1527346A1 Modulation of platelet adhesion based on the surface exposed beta-switch loop of platelet glycoprotein ib-alpha
05/04/2005EP1527189A2 Mutant proteinase inhibitors and uses thereof
05/04/2005EP1527188A1 Process for the production of increased amounts of correctly folded heterologous protein in inclusion bodies
05/04/2005EP1527184A2 Method of plastid transformation in asteraceae, vector for use therein and plants thus obtained
05/04/2005EP1527179A2 Il-7 drug substance, il- 7 comprising composition, preparation and uses thereof
05/04/2005EP1527178A2 Novel class ii cytokine receptors and uses thereof
05/04/2005EP1527177A2 Muc-1 antigen with reduced number of vntr repeat units
05/04/2005EP1527171A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
05/04/2005EP1527169A2 Leech extracts for stents
05/04/2005EP1527159A1 Probiotic propionibacterium jensenii 702
05/04/2005EP1527101A2 Specific antibodies for diagnosing heart failure
05/04/2005EP1527098A2 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
05/04/2005EP1527097A1 Method for purifying preproinsulin
05/04/2005EP1527096A2 Binding molecules
05/04/2005EP1527095A1 SYNTHETIC GENE CODING FOR HUMAN GRANULOCYTE-COLONY STIMULATING FACTOR FOR THE EXPRESSION IN E. coli
05/04/2005EP1527094A2 T-cell epitopes in erythropoietin
05/04/2005EP1527093A2 Gastric and colon cancer-associated antigens
05/04/2005EP1527092A2 Gpi anchored glycoprotein aca as a novel tumor marker
05/04/2005EP1527091A1 Corn root preferential promoters and uses thereof
05/04/2005EP1527090A1 Method of binding a compound to a surface
05/04/2005EP1527089A2 Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereof
05/04/2005EP1527088A1 Pegylated t20 polypeptide
05/04/2005EP1527087A2 Recombinant vesicular stomatitis virus vaccines for viral hemorrhagic fevers
05/04/2005EP1527086A1 Compounds binding to p-selectin
05/04/2005EP1527085A2 Antigens and their use as diagnostics and vaccines against species of plasmodium
05/04/2005EP1527084A2 Promoters exhibiting endothelial cell specificity and methods of using same
05/04/2005EP1527081A1 Glyconjugates comprising carbohydrate epitopes, methods for theirsynthesis, and their use for the treatment or prophylaxis of cancer
05/04/2005EP1527080A2 Campylobacter glycans and glycopeptides
05/04/2005EP1526865A2 Compounds for targeting hepatocytes
05/04/2005EP1526863A2 Using heat shock proteins to increase immune response
05/04/2005EP1506312A4 Metalloprotease peptide substrates and methods
05/04/2005EP1442022A4 Polyamide modulators of cox2 transcription
05/04/2005EP1364035A4 Vectors capable of imparting herbicide resistance and viral cross protection and methods
05/04/2005EP1362062B1 Concatameric immunoadhesion
05/04/2005EP1313503A4 Human tumor necrosis factor receptors tr21 and tr22
05/04/2005EP1276769A4 New neuromedin u receptor nmur2 and nucleotides encoding it
05/04/2005EP1221480B1 Polypeptide humanin inhibiting nerve cell death
05/04/2005EP1203078B1 Vaccine against lentiviral infections, such as the feline immune deficiency virus of the cat
05/04/2005EP1165767A4 Dna binding proteins that interact with npr1
05/04/2005EP1124984A4 Host cells expressing recombinant human erythropoietin
05/04/2005EP1086117A4 Cloning and identification of the motilin receptor
05/04/2005EP1065214B1 Novel physiologically active peptides and utilization thereof
05/04/2005EP1053330B1 Identification, production and use of staphylokinase derivatives with reduced immunogenicity and/or reduced clearance
05/04/2005EP1037990B1 Human sel-10 polypeptides and polynucleotides that encode them
05/04/2005EP1017798B1 Lunasin peptides
05/04/2005EP0935001B1 Novel vegf-like factors
05/04/2005EP0835266B1 Modified/chimeric superantigens and their use
05/04/2005EP0804734B1 Sterile and pyrogen-free columns coupled to protein for binding and removal of substances from blood
05/04/2005EP0781340B1 Vaccine against group A Streptococcal infection
05/04/2005EP0722498B1 Virus resistant or tolerant cells
05/04/2005EP0672139B1 Novel polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof
05/04/2005EP0668916B1 Haemophilus outer membrane protein
05/04/2005EP0456706B1 Molecular methods of hybrid seed production
05/04/2005CN1613011A Signal system and elements used therein
05/04/2005CN1612942A Viral capsid assembly intermediates
05/04/2005CN1612935A Expression vectors encoding epitopes of target-associated antigens and methods for their design
05/04/2005CN1612934A Human monoclonal antibodies to dendritic cells
05/04/2005CN1612896A Peptide purification by means of metal ion affinity chromatography
05/04/2005CN1612895A Conjugates comprising an antibody specific for the ED-B domain of fibronectin and their use for the detection and treatment of tumours
05/04/2005CN1612893A VEGF peptides and their use for inhibiting angiogenesis
05/04/2005CN1612892A Novel peptide having angiotensin convertase inhibitory effect
05/04/2005CN1612891A Process for producing modified peptide
05/04/2005CN1612890A Novel chimeric tnf ligands
05/04/2005CN1612756A Composition and method for treatment of wounds
05/04/2005CN1612750A TACI-immunoglobulin fusion proteins
05/04/2005CN1612748A Remedies for dry eye and diseases associated with dry eye
05/04/2005CN1611524A Polyethylene glycol amino acid N-internal ring carbonyl anhydride active derivatives, and medicinal bonding compound and gel thereof
05/04/2005CN1611513A Process of high purity albumin production
05/04/2005CN1611512A Poly peptide for therapeutic antitumour vaccive
1 ... 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 ... 2916